88 related articles for article (PubMed ID: 23098910)
21. Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease.
Masliah E; Rockenstein E; Adame A; Alford M; Crews L; Hashimoto M; Seubert P; Lee M; Goldstein J; Chilcote T; Games D; Schenk D
Neuron; 2005 Jun; 46(6):857-68. PubMed ID: 15953415
[TBL] [Abstract][Full Text] [Related]
22. The neuropathology of multiple system atrophy and its therapeutic implications.
Valera E; Masliah E
Auton Neurosci; 2018 May; 211():1-6. PubMed ID: 29169744
[TBL] [Abstract][Full Text] [Related]
23. Effects of the cholesterol-lowering compound methyl-beta-cyclodextrin in models of alpha-synucleinopathy.
Bar-On P; Rockenstein E; Adame A; Ho G; Hashimoto M; Masliah E
J Neurochem; 2006 Aug; 98(4):1032-45. PubMed ID: 16895578
[TBL] [Abstract][Full Text] [Related]
24. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.
Rockenstein E; Mallory M; Hashimoto M; Song D; Shults CW; Lang I; Masliah E
J Neurosci Res; 2002 Jun; 68(5):568-78. PubMed ID: 12111846
[TBL] [Abstract][Full Text] [Related]
25. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice.
Tozzi A; Costa C; Siliquini S; Tantucci M; Picconi B; Kurz A; Gispert S; Auburger G; Calabresi P
Neurobiol Aging; 2012 Aug; 33(8):1792-9. PubMed ID: 21684039
[TBL] [Abstract][Full Text] [Related]
27. Methylphenidate modifies overflow and presynaptic compartmentalization of dopamine via an α-synuclein-dependent mechanism.
Chadchankar H; Ihalainen J; Tanila H; Yavich L
J Pharmacol Exp Ther; 2012 May; 341(2):484-92. PubMed ID: 22344407
[TBL] [Abstract][Full Text] [Related]
28. Role of alpha-synuclein in synaptic glutamate release.
Gureviciene I; Gurevicius K; Tanila H
Neurobiol Dis; 2007 Oct; 28(1):83-9. PubMed ID: 17689254
[TBL] [Abstract][Full Text] [Related]
29. Facilitatory actions of serotonin type 3 receptors on GABAergic inhibitory synaptic transmission in the spinal superficial dorsal horn.
Fukushima T; Ohtsubo T; Tsuda M; Yanagawa Y; Hori Y
J Neurophysiol; 2009 Sep; 102(3):1459-71. PubMed ID: 19369358
[TBL] [Abstract][Full Text] [Related]
30. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein.
Rockenstein E; Schwach G; Ingolic E; Adame A; Crews L; Mante M; Pfragner R; Schreiner E; Windisch M; Masliah E
J Neurosci Res; 2005 Apr; 80(2):247-59. PubMed ID: 15765523
[TBL] [Abstract][Full Text] [Related]
31. Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures.
Park SS; Lee D
Eur J Neurosci; 2006 Jun; 23(11):2908-14. PubMed ID: 16819979
[TBL] [Abstract][Full Text] [Related]
32. Decreased reuptake of dopamine in the dorsal striatum in the absence of α-synuclein.
Chadchankar H; Ihalainen J; Tanila H; Yavich L
Brain Res; 2011 Mar; 1382():37-44. PubMed ID: 21276428
[TBL] [Abstract][Full Text] [Related]
33. Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by alpha-synuclein.
Park SS; Schulz EM; Lee D
Eur J Neurosci; 2007 Dec; 26(11):3104-12. PubMed ID: 18005066
[TBL] [Abstract][Full Text] [Related]
34. Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Mandler M; Valera E; Rockenstein E; Mante M; Weninger H; Patrick C; Adame A; Schmidhuber S; Santic R; Schneeberger A; Schmidt W; Mattner F; Masliah E
Mol Neurodegener; 2015 Mar; 10():10. PubMed ID: 25886309
[TBL] [Abstract][Full Text] [Related]
35. Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter.
Wersinger C; Sidhu A
Biochemistry; 2005 Oct; 44(41):13612-24. PubMed ID: 16216085
[TBL] [Abstract][Full Text] [Related]
36. NMDA receptor activation enhances inhibitory GABAergic transmission onto hippocampal pyramidal neurons via presynaptic and postsynaptic mechanisms.
Xue JG; Masuoka T; Gong XD; Chen KS; Yanagawa Y; Law SK; Konishi S
J Neurophysiol; 2011 Jun; 105(6):2897-906. PubMed ID: 21471392
[TBL] [Abstract][Full Text] [Related]
37. Alpha-synuclein binding to rab3a in multiple system atrophy.
Dalfó E; Ferrer I
Neurosci Lett; 2005 May 20-27; 380(1-2):170-5. PubMed ID: 15854772
[TBL] [Abstract][Full Text] [Related]
38. Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy.
Giasson BI; Mabon ME; Duda JE; Montine TJ; Robertson D; Hurtig HI; Lee VM; Trojanowski JQ
Acta Neuropathol; 2003 Sep; 106(3):243-50. PubMed ID: 12811584
[TBL] [Abstract][Full Text] [Related]
39. Epothilone D inhibits microglia-mediated spread of alpha-synuclein aggregates.
Valdinocci D; Grant GD; Dickson TC; Pountney DL
Mol Cell Neurosci; 2018 Jun; 89():80-94. PubMed ID: 29673913
[TBL] [Abstract][Full Text] [Related]
40. Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction.
Yu Z; Shi M; Stewart T; Fernagut PO; Huang Y; Tian C; Dehay B; Atik A; Yang D; De Giorgi F; Ichas F; Canron MH; Ceravolo R; Frosini D; Kim HJ; Feng T; Meissner WG; Zhang J
Brain; 2020 Jun; 143(6):1780-1797. PubMed ID: 32428221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
